San Francisco, 4 February 2019: The Report Diabetic Foot Ulcer (DFU) Treatment Market Analysis Report By Treatment (Biologics,
Wound Care Dressings, Therapy Devices), By Ulcer Type (Ischemic,
Neuro-Ischemic, Neuropathic), And Segment Forecasts, 2019 - 2025
The global diabetic foot ulcer treatment market size is expected to reach a value of USD 6.82 billion by
2025, according to a new report by Grand View Research, Inc., progressing at a
CAGR of 8.2% during the forecast period. Rising prevalence of diabetes,
increasing healthcare expenses, and rapidly growing geriatric population
worldwide are some of the major factors driving the diabetic foot ulcer
treatment market.
Diabetic foot ulcers are one of the most
common foot injuries that is caused due to diabetes mellitus. Management of
diabetic foot ulcers aims at fast healing and wound closure, by adopting a
multidisciplinary therapeutic approach so as to avoid amputation. Among
different types of treatment options available, biologics held the largest
share in the diabetic foot ulcer treatment market in 2017. This can be
attributed to strong revenue generated by growth factors that are prescribed
worldwide for their ability to promote generation of new cells and achieve
wound closure. Therapy devices and wound care dressings also offer significant
commercial opportunity due to their cost-effectiveness, ease of availability,
and wide use in combination with other treatments at every level of wound care
management.
Among different ulcer types, neuro-ischemic ulcers led
the market in 2017 with more than 50.0% market share due to higher patient
population suffering from the ulcer type globally. North America represented
the largest share in the global market in 2017 owing to rising prevalence of
diabetes, growing geriatric cohort, increased investment in R&D of novel
therapies, and developed healthcare facilities.
Access Research Report of Diabetic Foot Ulcer Treatment
Market @ www.grandviewresearch.com/industry-analysis/diabetic-foot-ulcer-dfu-treatment-market
Further Key Findings From the Study Suggest:
· The biologics segment commanded the largest
share in 2017 and is projected to retain its position through the forecast
period, due to increased adoption and potential approvals of growth factors
· North America dominated the DFU treatment
market in 2017 due to well-established favorable healthcare reimbursements and
infrastructure
· Asia Pacific is expected to witness the
fastest growth owing to expanding diabetes patient population driven by
increasing healthcare expenses and growing geriatric cohort
· The neuro-ischemic ulcers segment accounted
for the leading share in 2017. It is likely to experience the fastest growth
during the forecast period
· The foam and alginate dressings, skin
grafts, and negative pressure wound therapy segments are anticipated to exhibit
significant CAGR over the forecast period
· Some of the key players in this space are
ConvaTec, Inc.; Acelity L.P. Inc.; 3M Healthcare; Coloplast A/S; Smith &
Nephew Plc.; B. Braun Melsungen AG; Medline Industries, Inc.; Medtronic Plc.;
Organogenesis, Inc.; Molnlycke Health Care AB; and BSN Medical GMBH.
Browse more reports of this category by Grand View
Research at: www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the
global diabetic foot ulcer (DFU) treatment market on the basis of treatment,
ulcer type, and region:
Diabetic Foot Ulcer (DFU) Treatment Outlook
(Revenue, USD Million, 2016 - 2025)
·
Wound Care Dressings
·
Biologics
·
Therapy Devices
·
Antibiotic Medications
·
Others
Diabetic Foot Ulcer (DFU) Treatment Ulcer
Type Outlook (Revenue, USD Million, 2016 - 2025)
·
Neuropathic Ulcers
·
Ischemic Ulcers
·
Neuro-ischemic Ulcers
Diabetic Foot Ulcer (DFU) Treatment Region
Outlook (Revenue, USD Million, 2016 - 2025)
·
North America
·
Europe
·
Asia Pacific
·
Latin America
·
MEA
Access Press Release of
Diabetic Foot Ulcer Treatment Market@ www.grandviewresearch.com/press-release/global-diabetic-foot-ulcer-dfu-treatment-market
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
No comments:
Post a Comment